
### [MONDO:0006793](http://purl.obolibrary.org/obo/MONDO_0006793)
**Label:** hyperpituitarism

**Subclasses:** [MONDO:0006910](http://purl.obolibrary.org/obo/MONDO_0006910) (pituitary-dependent Cushing's disease), [MONDO:0019933](http://purl.obolibrary.org/obo/MONDO_0019933) (acromegaly), [MONDO:0010492](http://purl.obolibrary.org/obo/MONDO_0010492) (pituitary adenoma, growth hormone-secreting, 2), 

**Mapped go classes:** [GO:0007186](http://purl.obolibrary.org/obo/GO_0007186) (G-protein coupled receptor signaling pathway), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0007267](http://purl.obolibrary.org/obo/GO_0007267) (cell-cell signaling), [GO:0043235](http://purl.obolibrary.org/obo/GO_0043235) (receptor complex), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0004930](http://purl.obolibrary.org/obo/GO_0004930) (G-protein coupled receptor activity), [GO:0001588](http://purl.obolibrary.org/obo/GO_0001588) (dopamine neurotransmitter receptor activity, coupled via Gs), [GO:0004935](http://purl.obolibrary.org/obo/GO_0004935) (adrenergic receptor activity), [GO:0071880](http://purl.obolibrary.org/obo/GO_0071880) (adenylate cyclase-activating adrenergic receptor signaling pathway), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), 

**Class expressions from DL-Learner:**

- [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular) 75.00%
- [GO:0001588](http://purl.obolibrary.org/obo/GO_0001588) (dopamine neurotransmitter receptor activity, coupled via Gs) 75.00%
- [GO:0004952](http://purl.obolibrary.org/obo/GO_0004952) (dopamine neurotransmitter receptor activity) 60.36%
- Thing 50.90%
- [GO:0030594](http://purl.obolibrary.org/obo/GO_0030594) (neurotransmitter receptor activity) 41.67%
- [GO:0004930](http://purl.obolibrary.org/obo/GO_0004930) (G-protein coupled receptor activity) 33.11%
- [GO:0099600](http://purl.obolibrary.org/obo/GO_0099600) (transmembrane receptor activity) 30.49%
- [GO:0004888](http://purl.obolibrary.org/obo/GO_0004888) (transmembrane signaling receptor activity) 30.49%
- [GO:0038023](http://purl.obolibrary.org/obo/GO_0038023) (signaling receptor activity) 30.10%
- [GO:0004872](http://purl.obolibrary.org/obo/GO_0004872) (receptor activity) 29.90%
- [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity) 29.86%
- [GO:0060089](http://purl.obolibrary.org/obo/GO_0060089) (molecular transducer activity) 29.81%
- [GO:0044464](http://purl.obolibrary.org/obo/GO_0044464) (cell part) 26.99%
- [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) 26.86%
- [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) 26.24%


